Therefore, manipulation in TPM1 expression by either a pharmacological intervention targeting specific TPM1 or virus-mediated suppression of TPM1 could provide a unique avenue to gently restore balance in disrupted TPM1 systems to slow down the pathogenetic progression in neurodegenerative diseases including AD. Here, TPM1 is linked to Alzheimer disease.